Refractory or Relapsed Hodgkin's Lymphoma Treated with High Dose Chemotherapy Followed by Autologous Stem Cell Transplantation: Experience at SKMCH Lahore

Purpose: To review the outcomes of refractory and relapsed Hodgkin's Lymphoma in pediatric patients treated with high dose chemotherapy (HDC) followed by autologous stem cell transplantation (ASCT) at a single center. Materials and methods: All patients, up to the age of 18 years, with refractory or relapsed Hodgkin's Lymphoma who had complete or good-partial response to salvage chemotherapy were included in the study. All received HDC and ASCT during October 2010 to September 2013. Medical records of these patients were reviewed. The following variables were collected in addition to demographics and stage of di…